Related Experiment Video
Updated: Sep 28, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Does the angiotensin II receptor antagonist losartan improve cognitive function?
Michele A Tedesco1, Gennaro Ratti, Giovanni Di Salvo
1Department of Cardio-Thoracic and Respiratory Sciences, Second University of Naples, Naples, Italy. Tedesco@napoli.pandora.it
Insights
New antihypertensive drugs like angiotensin II receptor antagonists may improve cognitive function in hypertensive patients. This benefit extends beyond blood pressure reduction, suggesting broader impacts on brain health and quality of life.
Area of Science:
- Pharmacology
- Neurology
- Cardiology
Background:
- Chronic hypertension is linked to cerebrovascular and cardiovascular diseases.
- Hypertension is associated with reduced cognitive function, particularly in untreated patients.
- Newer antihypertensive agents may offer additional patient benefits beyond blood pressure control.
Purpose of the Study:
- To investigate the cognitive effects of angiotensin II receptor antagonists in hypertensive patients.
- To explore potential mechanisms beyond blood pressure reduction for cognitive improvements.
Main Methods:
- An initial clinical trial was conducted.
- The study involved patients with hypertension, including elderly individuals.
- The effects of the angiotensin II receptor antagonist losartan were assessed.
Main Results:
- Losartan demonstrated an improvement in cognitive function in hypertensive patients.
- Cognitive benefits were observed even in elderly participants.
- The observed cognitive improvements were not solely attributable to blood pressure reduction.
Conclusions:
- Angiotensin II receptor antagonists may positively impact cognitive function in hypertensive individuals.
- The renin-angiotensin system's biological actions likely play a role in these cognitive effects.
- Improving cognitive function in hypertension offers potential economic and quality-of-life benefits, especially for the aging population.
Abstract:
Newer classes of antihypertensive agents, such as angiotensin II receptor antagonists, may offer benefits to patients in addition to their ability to lower blood pressure. It is accepted that chronic hypertension contributes to the development of cerebrovascular and cardiovascular disease, and several studies have demonstrated a link between hypertension and reduced cognitive function, especially in patients not receiving antihypertensive medication. In an initial clinical trial, the angiotensin II receptor antagonist losartan was shown to improve cognitive function in patients with hypertension, including in those who were elderly (up to 73 years of age). This effect cannot be explained by a reduction in blood pressure alone and is likely to involve interactions with the diverse biological actions of the renin-angiotensin system. Improving or maintaining cognitive function in patients with hypertension may translate into economic benefits beyond those expected due to blood pressure control, and would result in considerable quality-of-life benefits for the aging population.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Development During Adulthood